OSAKA -- Japanese medical device maker Nipro is spending about 3 billion yen ($29.3 million) to build a new plant in India that will double its dialysis equipment production there, an effort to capitalize on a growing market in the subcontinent.
In Japan, Nipro controls the top share in dialyzers for artificial kidneys, which filter out waste and adjust water content in the blood. In terms of global share, the Japanese company trails only Germany's Fresenius. Nipro aims for the global crown by focusing on India.
